Fundraising Fox
Mestag
London, GB · Founded 2020 · 6 known investors
Find your way into Mestag
Sign up to see every warm intro you have to Mestag
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mestag team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures. The company advances agonist antibody programs and operates a RAFT target discovery platform to identify new therapeutic targets.
Founders & leadership
Mestag was founded in 2020 by Michael B. Brenner, Chris Buckley, Mark Coles, Soumya Raychaudhuri, and David A. Tuveson.
Investors · 6
How we know: GV (Google Ventures)'s portfolio page · the company's own site · a partner's Signal profile · funding news · european-biotechnology.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: SV Health Investors's portfolio page · the company's own site · funding news · european-biotechnology.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · funding news · european-biotechnology.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · funding news · european-biotechnology.com · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed financingApr 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Mestag went on to found or lead other companies.
Companies House · registry record
View on Companies House ↗- Registered name
- MESTAG LIMITED
- Company number
- SC366550
- Status
- Dissolved
- Company type
- Private limited company
- Incorporated
- 8 Oct 2009
- Dissolved
- 9 Mar 2012
- Registered office
- Coillemore, Newmore, Invergordon, Ross-Shire, IV18 0PG
- Nature of business (SIC)
- 25110 — Manufacture of metal structures and parts of structures
- Accounts
- last made up to 31 Oct 2010
Current officers
- Edmund Donald William Maclellan — secretary, appointed 8 Oct 2009
- James Kenneth Chalmers — director, appointed 8 Oct 2009
- Edmund Donald William Maclellan — director, appointed 8 Oct 2009
Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Mestag do?
- Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures. The company advances agonist antibody programs and operates a RAFT target discovery platform to identify new therapeutic targets.
- Who founded Mestag?
- Mestag was founded by Michael B. Brenner, Chris Buckley, Mark Coles, Soumya Raychaudhuri, David A. Tuveson in 2020.
- Who are Mestag's investors?
- Mestag's investors include GV (Google Ventures), SV Health Investors, Forbion, Johnson & Johnson Innovation – JJDC, Northpond Ventures, JJDC.
- Where is Mestag headquartered?
- Mestag is headquartered in London, GB.